Terumo announces first commercial clinical case using Quiremspheres

Terumo Europe NV has announced the first commercial clinical case using Quiremspheres—the next generation radioembolization microspheres for advanced unresectable liver cancer. Quiremspheres are the only...

MIRACLE I demonstrates high tumour control rate for drug-eluting microspheres

Goetz Richter, Clinic for Diagnostic and Interventional Radiology, Stuttgart, Germany, presented breaking data from the Miracle 1 multicentre hepatocellular carcinoma trial at The Symposium...

Cryoablation allows safe and effective local control of breast cancer

“Cryoablation of metastatic breast cancer is a safe and effective method that allows local control of the disease,” Claudio Pusceddu told delegates at the...

Hitting cancer with high-intensity ultrasound and immunotherapy

In a new study published in JCI Insight, UC Davis researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint...

Gireesh Mukund Warawdekar

Gregory John Slater

Constantinos T Sofocleous